EAGLE PHARMACEUTICALS, INC. short interest in 2018
In 2018, EAGLE PHARMACEUTICALS, INC.'s disclosed short interest ran from 21.16% of shares outstanding on 12 Jan 2018 to 18.97% on 31 Dec 2018, a change of -2.19 percentage points. The year's high was 22.36% on 15 Mar 2018 and its low 16.15% on 13 Jul 2018, averaging 18.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.01 days on 30 Apr 2018. Full history: EAGLE PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2018 in figures
- Start of year
- 21.16% (12 Jan 2018)
- End of year
- 18.97% (31 Dec 2018)
- Change
- -2.19 pp
- High
- 22.36% (15 Mar 2018)
- Low
- 16.15% (13 Jul 2018)
- Average
- 18.68%
- Highest days to cover
- 18.01 (30 Apr 2018)
- SEC filings marked
- 9
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 21.16% | 14.75 | |
| 31 Jan 2018 | 20.18% | 14.57 | |
| 15 Feb 2018 | 20.74% | 14.22 | |
| 28 Feb 2018 | 22.34% | 7.30 | 10-K filed, results (8-K) |
| 15 Mar 2018 | 22.36% | 13.96 | |
| 29 Mar 2018 | 21.37% | 15.01 | |
| 13 Apr 2018 | 20.34% | 15.51 | |
| 30 Apr 2018 | 19.31% | 18.01 | |
| 15 May 2018 | 17.93% | 9.14 | 10-Q filed, results (8-K) |
| 31 May 2018 | 16.39% | 10.31 | |
| 15 Jun 2018 | 17.48% | 8.67 | |
| 29 Jun 2018 | 17.19% | 10.33 | |
| 13 Jul 2018 | 16.15% | 12.10 | |
| 31 Jul 2018 | 16.18% | 11.12 | |
| 15 Aug 2018 | 17.19% | 10.38 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 17.12% | 11.93 | |
| 14 Sep 2018 | 16.44% | 13.38 | |
| 28 Sep 2018 | 17.62% | 9.79 | |
| 15 Oct 2018 | 17.55% | 13.63 | |
| 31 Oct 2018 | 18.94% | 7.69 | results (8-K) |
| 15 Nov 2018 | 19.24% | 9.12 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 17.88% | 12.44 | |
| 14 Dec 2018 | 18.16% | 10.09 | |
| 31 Dec 2018 | 18.97% | 13.86 |
See also: EAGLE PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.